Literature DB >> 489132

Liposomal enhancement of the immunogenicity of adenovirus type 5 hexon and fiber vaccines.

W J Kramp, H R Six, S Drake, J A Kasel.   

Abstract

Immunogenicity of adenovirus capsid proteins carried in liposomes was comparable to that with equivalent doses administered in Freund adjuvant, and both forms were more potent than aqueous vaccines.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 489132      PMCID： PMC414511          DOI： 10.1128/iai.25.2.771-773.1979

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  17 in total

1.  IMMUNIZATION OF VOLUNTEERS WITH SOLUBLE ANTIGENS OF ADENOVIRUS TYPE 1.

Authors:  J A KASEL; M HUBER; F LODA; P A BANKS; V KNIGHT
Journal:  Proc Soc Exp Biol Med       Date:  1964-10

2.  PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.

Authors:  W C WILCOX; H S GINSBERG
Journal:  Proc Soc Exp Biol Med       Date:  1963-10

3.  The adjuvant properties of liposomes.

Authors:  T D Heath; D C Edwards; B E Ryman
Journal:  Biochem Soc Trans       Date:  1976       Impact factor: 5.407

4.  Immunogenicity of liposomal model membranes.

Authors:  S C Kinsky
Journal:  Ann N Y Acad Sci       Date:  1978       Impact factor: 5.691

5.  Liposomes as immunological adjuvants.

Authors:  A G Allison; G Gregoriadis
Journal:  Nature       Date:  1974-11-15       Impact factor: 49.962

6.  Preparation of liposomes and a spectrophotometric assay for release of trapped glucose marker.

Authors:  S C Kinsky
Journal:  Methods Enzymol       Date:  1974       Impact factor: 1.600

7.  Release of macromolecular markers (enzymes) from liposomes treated with antibody and complement. An attempt at correlation with electron microscopic observations.

Authors:  T Kataoka; J R Williamson; S C Kinsky
Journal:  Biochim Biophys Acta       Date:  1973-03-16

8.  Effect of antibody-complement on multiple vs. single compartment liposomes. Application of a fluorometric assay for following changes in liposomal permeability.

Authors:  H R Six; W W Young; K Uemura; S C Kinsky
Journal:  Biochemistry       Date:  1974-09-10       Impact factor: 3.162

9.  Vaccination of experimental monkeys against Plasmodium falciparum: a possible safe adjuvant.

Authors:  W A Siddiqui; D W Taylor; S C Kan; K Kramer; S M Richmond-Crum; S Kotani; T Shiba; S Kusumoto
Journal:  Science       Date:  1978-09-29       Impact factor: 47.728

10.  Liposome toxicity in the mouse central nervous system.

Authors:  D H Adams; G Joyce; V J Richardson; B E Ryman; H M Wiśniewski
Journal:  J Neurol Sci       Date:  1977-03       Impact factor: 3.181
View more
  6 in total

Review 1.  Vaccine development for human mastadenovirus.

Authors:  Shiying Chen; Xingui Tian
Journal:  J Thorac Dis       Date:  2018-07       Impact factor: 2.895

2.  The effect of liposomal charge on the neutralizing antibody response against inactivated encephalomyocarditis and Semliki Forest viruses.

Authors:  C A Kraaijeveld; M Schilham; J Jansen; B Benaissa-Trouw; M Harmsen; A J van Houte; H Snippe
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

3.  In vivo induction of anti-herpes simplex virus immune response by type 1 antigens and lipid A incorporated into liposomes.

Authors:  P T Naylor; H S Larsen; L Huang; B T Rouse
Journal:  Infect Immun       Date:  1982-06       Impact factor: 3.441

4.  Immunization against experimental murine salmonellosis with liposome-associated O-antigen.

Authors:  J V Desiderio; S G Campbell
Journal:  Infect Immun       Date:  1985-06       Impact factor: 3.441

5.  Suppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.

Authors:  Jonathan B Rosenberg; Bishnu P De; Martin J Hicks; Kim D Janda; Stephen M Kaminsky; Stefan Worgall; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2013-06       Impact factor: 5.695

6.  Humoral and cellular immunity to hepatitis B virus-derived antigens: comparative activity of Freund complete adjuvant alum, and liposomes.

Authors:  Y Sanchez; I Ionescu-Matiu; G R Dreesman; W Kramp; H R Six; F B Hollinger; J L Melnick
Journal:  Infect Immun       Date:  1980-12       Impact factor: 3.441
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.